DRUG APPROVALS: JANUARY 2012
JAN 4: SUBSYS (FENTANYL) SUBLINGUAL SPRAY
TREATMENT- PAIN
JAN 17: VORAXAZE (GLUCARPIDASE) INJECTION
TREATMENT- TOXIC METHOTREXATE LEVELS
JAN 20: ZETONNA (CICLESONIDE) NASAL AEROSOL
TREATMENT- ALLERGIC RHINITIS
JAN 23: PICATO (INGENOL MEBUTATE) TOPICAL GEL
TREATMENT- ACTINIC KERATOSIS
JAN 27: INLYTA (AXITINIB) TABLETS
TREATMENT- RENAL CELL CARCINOMA
JAN 27: BYDUREON (EXENATIDE) EXTENDED-RELEASE INJECTABLE SUSPENSION
TREATMENT- DIABETES MELLITUS TYPE II
JAN 30: JENTADUETO (LINAGLIPTIN & METFORMIN HYDROCHLORIDE) TABLETS
TREATMENT- DIABETES MELLITUS TYPE II
JAN 30: ERIVEDGE (VISMODEGIB) CAPSULES
TREATMENT- BASAL CELL CARCINOMA
JAN 31: KALYDECO (IVACAFTOR) TABLETS
TREATMENT- CYSTIC FIBROSIS
